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Bisphenol S (BPS) is a substitute for bisphenol A (BPA), and widely used in 
the manufacture of polycarbonate plastics, epoxy resins and consumer products. 
BPS has been reported as endocrine disruption chemicals (EDCs) that cause 
weak estrogenic or anti-androgenic activity. Although many studies related to 
BPS have been conducted, the steroidogenesis disruption of prenatal exposure 
to BPS on mammals study has not yet been elucidated.  
The objective of the study is to identify differences in steroidogenesis and 
steroid hormones metabolites due to prenatal exposure to BPS by sex and time 
point. In present study, the C57BL/6 pregnant mice were exposed to BPS 
5mg/kg bw/day, 50mg/kg bw/day, 250mg/kg bw/day through drinking water 
for about 10days (gestation period 9 days – delivery). F1 generation was 
sacrificed at 8 weeks and 23 weeks of age, and physiological characteristics, 
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serum, fat, organs were collected. Using the collected serum, six hormones 
(Gonadotropin releasing hormone (GnRH), Follicle stimulating hormone 
(FSH), Luteinizing hormone (LH), Progesterone (P4), Testosterone (T), 
Estradiol (E2)) were measured by ELISA kit. In addition, UPLC-qTOF was 
used to measure steroid hormones and their metabolites involved in the 
synthesis and metabolism of steroid hormones in serum. Physiological 
statistical analysis of general linear model showed a significantly different 
tendency depending on sex, age and exposure concentration. In particular, both 
male and female mice group showed significant differences in puberty (8-week-
old) than in adulthood (23-week-old). The hormones involved in the HPG axis, 
in the 250mg/kg bw/day group in 8-week-old female and male group, LH and 
T values tended to increase as GnRH increased. Among the metabolites related 
to steroidogenesis and metabolism pathway, 23-week-old male and female 
group, 8-week-old male group showed a tendency to metabolize from 
pregenolone to tetrahydrocorticosterone at all dose. This study showed that, 
compared to BPS in vitro test results, prenatal exposure to BPS cause 
androgenic activity, unlike a weak estrogenic agonist activity. However, since 
the steroid hormone synthesis in the adrenal gland cannot be detected, it is 
difficult to explain the UPLC-qTOF detection results. The results of the study 
showed that the effects of physiological and hormones on prenatal exposure to 
BPS were significantly different according to the sex, exposure concentration, 
time point. Therefore, in present study provides information on changes in the 
circulation system of steroid hormone synthesis and metabolism caused by 
exposure to BPS in rodents and could be used for the further research of toxic 
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The principles of “Developmental Origins of Health and Disease” (DOHaD) 
describe how early life exposures in conception, pregnancy, infancy and 
childhood between maternal and environmental factors can have a significant 
impact on health and disease risk in later life (Barker, 1990, 1995; Li et al., 
2008; Charles et al., 2016). One of the environmental factors is endocrine-
disrupting compounds (EDCs). Exposure to EDCs, a group of biologically 
active compounds that mimic or antagonize the effects of endogenous 
hormones, during critical stages of differentiation can interfere with the balance 
of hormones necessary for normal development, and result in altered gene 
expression that is not detectable until puberty or much later in life (Zoller et al., 
2016).  
Bisphenol S (BPS;4,4′-sulfonyldiphenol) is composed of two phenol groups 
on each side of a sulfonyl group. It has been used in the manufacturing of epoxy 
resins and polycarbonate plastics as constituents of a wide variety of consumer 
products (Liao et al., 2012a; Simoneau et al., 2011). It has been introduced as a 
substitute for bisphenol A (BPA), one of the representative endocrine disrupting 
chemicals, due to the structural analogy and higher thermal stability (Lotti et 
al., 2011). BPS has also been detected in surface water, sediment, and sewage 
effluent, generally at lower concentrations than BPA, but in the same order of 
magnitude (Fromme et al. 2001; Song et al. 2014; Yang et al. 2014). In human, 
BPS has been detected in urine at concentrations and frequencies comparable 
to BPA (Liao et al. 2012a; Zhou et al. 2014).  
Several studies have demonstrated that BPS shows weak estrogenic activity 
both in vivo and in vitro. An in vitro study demonstrated that BPS induced 
membrane ERα – mediated pathways and actions: MAPK(mitogen-activated 
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protein kinase) signaling, cell proliferation, and activation of caspase 8 (Vi?̃?as 
and Watson 2013a, 2013b). Another study demonstrated that BPS has 
androgenic activity similar to BPA (Molina-Molina et al., 2013). A recent study 
demonstrated that BPS non-monotonically reduced the basal testosterone 
secretion in human fetal testes and exhibited anti-androgenic effects (Eladak et 
al., 2015). In vivo study reported that BPS exposure was estrogenic in rats via 
increases in uterine weight, and also found to bind the estrogen receptor 
(Yamasaki et al., 2004). A recent study demonstrated that BPS decreases in 
gonad weight in males and females, and also E2 levels were increased in males 
and in females in zebrafish (Ji et al., 2013). Although many studies related to 
BPS have been conducted, the steroidogenesis disruption of BPS on mammals 
study has not yet been elucidated.  
We performed the present study to fill this knowledge gap as follows: 
endocrine disruption effects of BPS of reproduction-related hormones along 
hypothalamus-pituitary-gonadal (HPG) axis (Fig.1) were studied. And also 
steroid hormones and metabolites associated with steroidogenesis and 
metabolism pathway (Fig.S3) were studied. The objective of the present study 
is to identify differences in steroidogenesis and steroid hormones metabolism 











Fig 1.  Hormone secretion in the hypothalamus-pituitary-gonadal 
(HPG). GnRH, Gonadotropin-releasing hormone; LH, Luteinizing 
hormone; FSH, Follicle-stimulating hormone; E2, Estradiol; T, 
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Bisphenol S (BPS, CAS No. 80-09-1, purity 98%) were purchased from 
Sigma-Aldrich Laboratories, Inc. (St. Louis, MO, U.S.A.). Acetonitrile and 
Water (HPLC grade) were purchased from Avantor (Center Velly, PA, U.S.A.). 
And Ethyl alcohol (99.8%, CAS No. 64-17-5), Formic acid (98% pure, CAS 




2.2 Animals and treatment 
 
All experimental animals were housed and handled in accordance with 
Guide-lines and Regulations in Seoul National University. 12 weeks to 14 
weeks old C57BL/6 pregnant mouse were used in this study and purchased 
from Koatech, Korea. C57BL/6 pregnant mouse were maintained under 
controlled temperature (22.5-25 ℃) and humidity (50-70%) with a 12hr light-
dark cycle (06:00-18:00). BPS dissolved in 0.5% ethanol was administrated 
orally via distilled water in glass bottle to treatment pregnant mouse from 
gestation day (GD) 9 to until delivery (GD18-19). During the gestation period, 
10 pregnant mouse from the control group (Vehicle, V) and 26 pregnant mouse 
from the treatment group were treated daily at dose of 0 (V), 5 (L), 50 (M), 250 
(H) mg BPS/ kg of body weight/ day in 0.5% Ethanol. Since the reference dose 
(RfD) of BPS has not yet established, the administration concentration refers to 
the RfD of BPA. The Lowest-observed-adverse-effect-value of BPA was 50mg/ 
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kg bw/ day (U.S. Environmental Protection Agency National Center for 
Environmental Assessment). We selected 10 times lower concentration and 10 
times higher concentration based on NOAEL. On the day of birth (postnatal 
day (PND) 0), litters born to treated and control dams were divided by sex, time 
point after weaning day. 5 male, female pups (F1) per cage were housed with 
distilled water and normal diet. Feed, water and cages were changed once a 
week. The study was conducted according to protocols approved by the 
Institutional Animal Care and Use Committee of Seoul National University, 
Korea (IACUC No. 160930-3-1). 
 
 
2.3 Measurement of physical parameters and sampling procedures 
 
Body weight of pups were measured every weeks by use of an electronic 
balance. And Body length and Anogenital distance (AGD) were measured by 
use of a digital caliper (Bluebird Inc., Korea). Each animal per dose was 
sacrificed at 8 weeks old and 23 weeks old, respectively. Blood was collected 
and centrifuged at 15,000 rpm for 15min at room temperature. The serum was 
then collected and stored at –80℃ until further analysis. All organs were 










2.4 ELISA for Gonadotropin-releasing hormone (GnRH) and 
steroid hormones 
 
All hormones were measured using serum. Luteinizing hormone (LH), 
Gonadotropin-releasing hormone (GnRH), Follicle-stimulating hormone 
(FSH), Estradiol (E2), Testosterone (T) and Progesterone (P4) were measured 
using an enzyme-linked immunosorbent assay (ELISA) kits (LH, Lifespan 
Biosciences Inc., U.S.A; GnRH, FSH, E2, Cusabio Biotech Co., China; T, P4, 




2.5 Sample preparation 
 
All serum samples were thawed at 4°C before pretreatment. A 4μL aliquot 
of each serum sample was used for metabolite extraction using UPLC-QTOF-
MS. Place 40 μL of serum in a sterile screw tube, after addition of 120 μL 
acetonitrile to serum. The mixture was successively vortex-mixed for 1min, and 
then incubated at −20°C for 20 min, and centrifuged at 10,000×g for 10 min at 
4 °C. Then, the resulted supernatant was evaporated to dryness under N2, and 
a 40 μL aliquot of ultrapure water was added into each tube to reconstitute the 
dried sample. Afterwards, the solution was vortex-mixed for 1min, and the 
supernatant was transferred into a total recovery glass vial (Waters, USA) 
pending UPLC-MS analysis. All samples were kept at 4°C inside the auto-




2.6 UPLC-QTOF-MS analysis 
 
Ultra Performance Liquid Chromatography (UPLC) was performed using a 
Waters ACQUITY UPLC H-class (Waters Corp., Milford, MA.). A 5  μL 
aliquot of each sample solution was injected into an ACQUITY BEH C18 
column (2.1mm × 100mm, 1.7 μm). The column temperature was set to 30 °C, 
and the flow rate of mobile phase was 400 μL/min. Analytes were eluted from 
column with a gradient, where phase A was water with 0.1% formic acid and 
phase B was acetonitrile with 0.1% formic acid. The initial composition of B 
was 5%, and increased linearly to 80% in 10min, and then to 100 % in the 
following 10 min. The mobile phase maintained at 100% B for 5 min and 
another 5 min at 5% B before the next injection. Each run time was 30 min 
(Dong et al., 2015). 
Next, MS analysis was performed using a Waters Synapt G2-Si MS (Waters 
Corp., Milford, MA) using an electrospray ionization (ESI) operated in the 
positive and negative ion mode. The mass spectrometers performed alternative 
high- and low- energy scans, known as the MSE acquisition mode. The 
operating parameters were as follows; cone voltage, 40V; capillary voltage, 
5.0kV; source temperature, 120℃; desolvation temperature, 250℃; cone gas 
flow, 30 L/h; and desolvation gas flow, 600 L/h. The scan mass range was from 
100 and 1,000 m/z. Data was scanned from m/z 50 to 1000 with a scan time of 
0.01 s (Dong et al., 2015). 
The QTOF-MS data was collected in continum mode, using the lock spray 
to ensure accuracy and reproducibility. A concentration of 1ng/mL leucine-
enkephalin was used as lock mass (m/z 556.2771 (ESI+), m/z 554.2615 (ESI-)). 
The lock spray frequency was set at 10s, and the lock mass data were averaged 
over 10 scans for correction. All of the data acquisition was controlled using 
Waters MassLynx software (Waters Corp. Milford, MA) with the MSE program.  
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2.7 Data processing 
 
All MSE data were processed within UNIFI software (Waters Corp., Milford, 
USA). We created the user library of over 90 species of metabolites presented 
in Fig S1. Based on this user library, All MSE data peaks were identified through 
UNIFI. Among the identified peaks compared the mass error, the number of 
fragments, and the mass error of the fragment to determine a meaningful peak. 
And then, the three-dimensional data including peak number (RT-m/z pair), 
sample name, and normalized peak areas were exported to the EZ info software 
3.0.3 (UMETRICS) for multivariate analysis. The detected metabolites were 
compared with the control group to determine the change of metabolic pathway. 
 
 
 2.8 Statistical analysis 
 
The physiological data were presented as median (p50) divided vehicle 
median with standard error (p75) ratio. The ELISA kit data were presented as 
mean with standard deviation (mean ± SD). Statistical analysis was performed 
using SAS 3.3 software (SAS Institute Inc., Cary, U.S.A). Kit data were not 
normally distributed, so these data were transformed natural log (ln), followed 
by statistical analysis. General linear model analysis (GLM) were performed to 






3.1 Body weight, Body length, AGD 
The physical measurements corresponding to each group are shown in Fig 2, 
Fig 3, Fig 4. In the graph, the median value of the control group (Vehicle) was 
set as the reference (Vehicle p50 / Vehicle p50 =1). The median value of each 
dose was divided by the median value of the control group. Body weight did 
not show a significant difference, however the tendency was sex difference and 
dose difference. Body length of the male mice was shorter than that of the 
control group, while the length of the H group was longer. In female mice, the 
L group was similar in body length to the control group, and the M and H groups 
had longer than the control group. Especially, the H group of 8-week-old female 
mice had significantly longer body length, however there was no significant 
difference at 23-week-old. AGD (Anogenital distance) was significantly 
different by sex. In 8-week-male mice, AGD of mice exposed to M (50mg 
BPS/kg/ day) was significantly longer than that of control mice. AGD of mice 
exposed to L (5mg BPS/kg/ day) and H (250mg BPS/ kg/ day) concentration 
was slightly longer than that of the control group. However, in 23-week-male 
mice AGD of mice exposed to L was shorter than that of AGD of control group, 
and AGD of mice exposed to H was significantly longer than that of AGD of 
control group. In female mice, AGD was longer at 8-week-old than control, and 







(A) Body weight ratio of male mice                    (B) Body weight ratio of female mice                                         
Age (week)












































































Figure 2. Body weight ratio by sex, time point and dose of BPS 
All value is presented as median (p50) / vehicle median (p50) ± standard error (p75).  
L = 5mg BPS/kg /day, M = 50mg BPS/kg /day, H = 250mg BPS/kg /day 
*p<0.05 significant difference compared to control (Vehicle). 





(A) Body length ratio of male mice                    (B) Body length ratio of female mice                                         
Age (week)







































Figure 3. Body length ratio by sex, time point and dose of BPS 
All value is presented as median (p50) / vehicle median (p50) ± standard error (p75). 
L = 5mg BPS/kg /day, M = 50mg BPS/kg /day, H = 250mg BPS/kg /day  
*p<0.05 significant difference compared to control (Vehicle). 












































 (A) AGD ratio of male mice                             (B) AGD ratio of female mice    
 
Figure 4. AGD (Anogenital distance) ratio by sex, time point and dose of BPS 
All value is presented as median (p50) / vehicle median (p50) ± standard error (p75).  
L = 5mg BPS/kg /day, M = 50mg BPS/kg /day, H = 250mg BPS/kg /day 
*p<0.05 significant difference compared to control (Vehicle). 
**p<0.01 significant difference compared to control (Vehicle). 
Age (week)







































































3.2 Effect of BPS on organ weights of mice 
 
Fig 5, Fig 6, Fig 7 are shown the organ weights p50 ratio such as gonad 
(testis in male, ovary in female), liver, kidney adjusted to organ weights 
median of control group by sex, time point. Each organs ratio were shown   
the tendency by sex difference and dose difference. Gonad was smaller 
than control group at all sex, dose at 8-week-old. In particular, the female 
mice exposed to L (5mg BPS/ kg /day) group were significantly smaller in 
size. However, at 23-week-old, the gonad size of exposure group was 
similar to that of the control group. In Liver, any differences did not show   
by sex, time point, dose. In kidney, there was a significantly differences at 
8-week-female mice exposed to L, H group. Growing to 23-week-old 
female mice was shown a tendency to similar to that of the control group 
at H group. However, the kidney ratio of L group did not change with age 




(A) Testis ratio of male mice                          (B) ovary ratio of female mice  
 
Figure 5. Gonad ratio by sex, time point and dose of BPS 
All value is presented as median (p50) / vehicle median (p50) ± standard error (p75).  
L = 5mg BPS/kg /day, M = 50mg BPS/kg /day, H = 250mg BPS/kg /day 
*p<0.05 significant difference compared to control (Vehicle). 
**p<0.01 significant difference compared to control (Vehicle). 
Age (week)







































































(A) Liver ratio of male mice                          (B) Liver ratio of female mice  
Figure 6. Liver ratio by sex, time point and dose of BPS 
All value is presented as median (p50) / vehicle median (p50) ± standard error (p75).  
L = 5mg BPS/kg /day, M = 50mg BPS/kg /day, H = 250mg BPS/kg /day 
*p<0.05 significant difference compared to control (Vehicle). 
**p<0.01 significant difference compared to control (Vehicle). 
Age (week)




































































(A) Kidney ratio of male mice                          (B) Kidney ratio of female mice  
Age (week)





































Figure 7. Kidney ratio by sex, time point and dose of BPS 
All value is presented as median (p50) / vehicle median (p50) ± standard error (p75).  
L = 5mg BPS/kg /day, M = 50mg BPS/kg /day, H = 250mg BPS/kg /day 
*p<0.05 significant difference compared to control (Vehicle). 
**p<0.01 significant difference compared to control (Vehicle). 
Age (week)




































3.3 Effect of BPS on fat tissue of mice 
 
Figure S1 was showed the relative ratio of gonadal fat median (around testis 
in male, around ovary in female). Also, Figure S2 was showed the median ratio 
of total fat (visceral adipose tissue, subcutaneous adipose tissue, brown adipose 
tissue) by sex, time point. Any Differences did not show in median ratio of 
gonadal fat compared with control group. However, it decreased slightly 
compared with control group at L group. In total fat, at 8-week-old, the weight 
of total fat in males was lower than that of the control, but the total fat tended 
to increase from 8-week-old to 23-week-old. However, in the case of females, 




3.4 Hormone levels in serum 
The effects of BPS on hormone levels in the serum related to Hypothalamus-
Pituitary-Gonad (HPG) axis of 8weeks old mouse and 23weeks old mouse are 
shown in Figure 8. The male’s GnRH level was higher than female. There was 
a sex difference in GnRH. Especially in 8 weeks old males, M (50 mg BPS/kg 
bw /day) group and H (250mg BPS/kg bw/day) group were significant increase 
compared with control group (p < 0.05, p < 0.01). In 23 weeks old males, no 
significant differences were observed in the levels of serum GnRH among the 
four group, but more than higher in L (5mg BPS/kg bw/day) group and H 
(250mg BPS/kg bw/day) group compared with control group. Concentration of 
LH was observed significantly increase in 8 weeks male mouse group than 8 
weeks female mouse group. But, no differences was observed by dose of BPS. 
And there was no sex difference, dose difference at 23 weeks old mouse. 
However, at H group of all male groups, LH concentration was higher than the 
control group. Concentration of FSH levels also no significant difference were 
significantly difference in L group at 8-week-old male mice. Progesterone was 
not significantly different by time points, but it was higher in females than 
males. In 8-week-old male mouse’s progesterone levels increased in M, H 
group. Especially, In 8-week-old female mouse’s progesterone levels were 
significantly higher than control group in H group. Testosterone was usually 
higher in all male groups and sex differences at 8 weeks were significantly 
prominent. At 8 weeks of age, the concentration of male control group was 
about 6 times higher than that of female control group. In addition, testosterone 
levels were significantly higher in the 8 weeks old, M and H group in male than 
in the control group (p<0.01). Also it was significantly higher in the 8 weeks 
old female mice, H male group than in the control group (p<0.01). In estradiol, 
there was no significant differences in any group. In 8-week-old male L group, 
estradiol concentration was slightly increased compared to the control group, 
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(A) Levels of Gonadotrophin-releasing hormone  
 

















































 (C) Levels of Follicle stimulate hormone 
 




























































(E) Levels of Testosterone 
 
(F) Levels of Estradiol 
 
 
Figure 8. Hormone levels in serum by sex, time point 
All value is presented as mean ± standard deviation. GnRH, Gonadotropin-releasing hormone; LH, 
Luteinizing hormone; FSH, Follicle stimulate hormone. 0, 0mg BPS/kg BW/day (Control); 5, 50mg 
BPS/kg BW/day; 50, 50mg BPS/kg BW/day; 250, 250mg BPS/kg BW/day; 
*p<0.05 significant difference compared to control 





















































3.3 Identification of metabolites involved in steroidogenesis and 
metabolism pathways  
All identification of metabolites of component name, observed m/z, mass 
error, retention time (RT) and adducts were listed in table S1. 13 metabolites 
have been identified in the androgen group. 10 metabolites have been identified 
in the estrogen group. In the progestin group, 13 metabolites were founded. And 
In the corticoids group, 17 metabolites were observed. 
Figure 9, 10 showed changes of the steroid metabolism pathway according 
to sex, according to age. In 8-week-old female, it was difficult to explain the 
metabolic direction because there were few metabolites detected. Just, estradiol 
was found to be higher in the group with BPS concentration of 5mg/kg bw/day 
compared to the other concentration groups. Other than these, hormones in the 
pathway of synthesis of corticosterone were detected to a small extent. In the 
exposed group of 8 weeks old male, metabolites contained in the same 
metabolic pathway were detected in the corticoids, but not in the control group. 
Especially, 11-Deoxycorticosterone, Corticosterone and 3a,21-Dihydroxy-5b-
pregnane-11,20-dione were detected in all treatment group. These metabolites 
are involved in the pathway in which corticosterone is synthesized and 
metabolized. The detection rates of these metabolites were in the order of dose 
of BPS 5, 250 and 50. 
In 23 weeks old female, 11-deoxycortisol and 17a,21-Dihydroxy-5b-
pregnane-3,11,20-trione of corticoids group were detected at very high. 
Although the number of metabolites detected to explain the specific pathway 
was insufficient, both 17a-hydroxyprogesterone and 11b-hydroxyprogesterone 
of the commonly detected pregestins group were metabolites related in 
corticoids metabolism pathway. The metabolites were the most abundant in the 
BPS 5 group, and the control and BPS 50 were similar. Also 16a-Hydroxy-
24 
 
androstenedione, Androstenedione and Testolactone were detected in BPS 5 
group.  In 23 weeks old male, 21-deoxycortisol and 17a,21-Dihydroxy-5b-
pregnane-3,11,20-trione of corticoids group were detected at very high. 
However, this is insufficient to explain the metabolic pathway. Especially, the 
BPS 250 group cannot explain the metabolic pathway because the detected 
metabolite is rare. However, in the control and BPS 5 groups, metabolites in the 
direction of metabolism to pregnenolone → progesterone → 11b-
hydroxyprogesterone → corticoids group → tetrahydrocorticosterone → 
3a, 21-dihydroxy-5b-pregnane-11,20-dione were detected. In addition, these 












Figure 9. Relative quantification of steroid metabolites of 8weeks old mouse. (A) Female (B) Male.  











Figure 10. Relative quantification of steroid metabolites of 23 weeks old mouse. (A) Female (B) Male.  
Each bar and error bar represent area mean and standard deviation of samples.
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.Ⅳ. Discussion  
Recognizing that developing organisms are uniquely sensitive to 
perturbation by chemicals with estrogenic and/or endocrine disrupting activity, 
we designed the current study to determine if exposure to BPS during critical 
developmental windows could disrupt steroid synthesis and metabolism 
pathway, such that they may respond abnormally to estrogen-like chemicals in 
later life. In present study, we examined HPG axis related six hormones and 
steroid hormone metabolites in order to investigate whether prenatal exposure 
to bisphenol S in mice induced disturbance of steroidogenesis and metabolism 
pathways.  
In the results of physiologic characteristics, it showed that the effects of 
physiological on prenatal exposure to BPS were significantly different tendency 
according to the sex, exposure concentration, time point. In particular, kidney 
and ovary, total fat were different by dose. 5mg/kg bw/day group showed that 
the weight of the ovary was significantly reduced compared to the control group 
in 8-week-old group. This observation is expected to be due to the inhibition of 
follicular growth around puberty by exposure to infants to BPS. However, it is 
difficult to determine whether the decrease in ovarian weight in 8-week-old is 
due to the influence of BPS, since the ovarian weight in adult stage is different 
according to the ovarian follicular developmental stages. Previous research 
demonstrated that gestational exposure to bisphenol A in mice, ovarian weight 
at PND 30 was significantly reduced in 1, 10 mg /kg bw/day group, however at 
PND 70 there was no significant differences among the groups (Nah et al., 
2011). But, in another study demonstrated that exposure to bisphenol S has been 
shown to increase the weight of female utero (Yamasaki et al., 2004). Kidneys 
showed different tendency according to sex. In females, the relative ratio of the 
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kidneys was increased according to the dose, while in the male, the relative 
ratio of the kidneys was decreased only at the concentration of 250mg BPS/kg 
BW/day at 23-week-old. This can be regarded as a phenotype that bisphenol S 
disturbs the adrenal steroid hormone or affects kidney toxic such as oxidative 
damage. In precious study, it has been reported that the administration of 240 
mg BPS /kg BW/day to rats increased the weight of kidneys and caused liver 
and kidney toxicity (Sangai et al.,2014). In males total fat ratio was increased 
at 8-week-old of 50mg/kg BPS/day. However, At 23 weeks of age, it was 
similar to the total fat weight of the control group. This causes a change in sex 
hormones, and prenatal exposure to bisphenol S causes childhood disturbances 
in adulthood. 
 Testosterone is essential for germ cell survival and development in the testes. 
It is synthesized from cholesterol as a substrate in Leydig cells through a series 
of reactions catalyzed by four enzymes : P450scc, 3β-HSD, CYP17a1 and 17
β-HSD (Payne and Hales et al., 2004). P450scc converts cholesterol to 
pregnenolone, which is the first rate-limiting and hormonally-regulated step in 
the synthesis of all steroid hormones (Hanukiglu et al., 1992). StAR plays an 
important role in transferring cholesterol from the outer mitochondrial to the 
inner mitochondrial membrane in Leydig cells (Manna and Stocco et al., 2005). 
In the present study, the change in sex steroid hormone levels may cause 
subsequent steroidogenesis dysfunction by interfering with the regulatory 
mechanisms of the HPG axis. Another results of our study was that the serum 
levels of GnRH increased with increasing dose of BPS in 8-week-old males, 
and the level of testosterone was significantly increased compared with control 
in 8-week-old females. This observation is consistent with the fact that there 
are feedback regulatory mechanisms in place to maintain hormonal 
homeostasis along the HPG-axis. GnRH secretion from the hypothalamus 
stimulates the pituitary gland to secrete LH, it combined with the LH receptor 
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of the testis. LH stimulates testicular synthesis and secretion of testosterone 
from the Leydig cells of males. In this study, there was a negative feedback that 
LH decreased as testosterone increased in both sexes. This result is different 
from the previous BPA exposure study. Prenatal exposure to BPA reduced 
expression levels of GnRH and FSH, also serum T levels in male mice (Wei et 
al., 2011). Also, low dose BPA exposure decreases pituitary LH secretion, and 
decreases Leydig cell T production. But, BPA at milligram doses did not affect 
serum LH and T levels or Leydig cell T production (Benson et al., 2004). 
Therefore, the differential pattern of decreases observed in the serum levels of 
LH, T at varying BPA doses implies that dose response of BPA can vary 
depending on which dose is set because it represents the U-shape. Based on 
these and other studies, BPS also suggests that the dose response of the U-shape 
may be expressed. 
The limitation of this study is that hypothalamus-pituitary-adrenal (HPA) 
axis and hypothalamus-pituitary-thyroid (HPT) axis cannot observed. Although 
the role of estrogenic, androgenic activity of BPS has been demonstrated in 
vitro, there is no previous study on the role of corticoids, and this study also 
lacked the adrenal part, so the explanation of the pathway of corticoid synthesis, 
one of steroidogenesis, was not clear. As a result, many metabolites of 
corticoids were detected. In both groups of female and male at 23-week-old, 
were metabolized to pregnolone → tetrahydrocorticosterone pathway 
according to exposure dose. However, due to the limitations of this study, the 
corticoids pathway lacked explanation for the steroidogenesis. Another 
limitation is that the genes involved in steroidogenesis and metabolism pathway 
are not considered. The results of HPG axis related hormones, their metabolites 
and physiologic characteristics did not prove that prenatal exposure to BPS 
causes endocrine disrupting disorders. Therefore further studies additionally 
are needed to explain better disturbance mechanisms of BPS by observing the 
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steroidogenesis and metabolism pathway at the gene level. 
BPA and substitute of BPA compounds are well-known as weak estrogen 
agonists (Casals-Casas et al., 2011). Accordingly, we were shown disruption of 
steroidogenesis and metabolism due to exposure to BPS in rodent. Also, we 
examined when the disturbance of F1 generation from prenatal exposure to BPS 
occurred. The present study is the first report to observe the circulation system 
from synthesis of steroid hormone to metabolic pathway to investigate the 








In conclusion, the present study investigated differences in steroidogenesis 
and steroid hormones metabolism changes of F1 by sex and time point during 
the gestation period, exposure to BPS to C57BL/6 pregnant mouse. As a result 
we were observed disruption of steroidogenesis due to exposure to BPS in 
rodent. Overall the results of the study showed that the effects of physiological 
and hormones on prenatal exposure to BPS were significantly different 
tendency according to the sex, exposure concentration, time point. Also, we 
examined when the disturbance of F1 generation from prenatal exposure to BPS 
occurred. Therefore our study could be applied to the study on the mechanism 
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Disruption of the steroidogenesis and 
steroid metabolism pathway in C57BL/6 






Figure S1. Gonadal fat ratio by sex, time point and dose of BPS. 
 
Figure S2. Total fat ratio by sex, time point and dose of BPS. 
 
Figure S3. Steroidogenesis and steroid metabolism pathways. 
 
 





(A) Gonadal fat ratio of male                           (B) Gonadal fat ratio of female 
Age (week)


































































Figure S1. Gonadal fat ratio by sex, time point and dose of BPS 
All value is presented as median (p50) / vehicle median (p50) ± standard error (p75).  
L = 5mg BPS/kg /day, M = 50mg BPS/kg /day, H = 250mg BPS/kg /day 
*p<0.05 significant difference compared to control (Vehicle). 
**p<0.01 significant difference compared to control (Vehicle). 
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(A) Total fat ratio of male                            (B) Total fat ratio of female 
Age (week)








































































Figure S2. Total fat ratio by sex, time point and dose of BPS 
All value is presented as median (p50) / vehicle median (p50) ± standard error (p75).  
L = 5mg BPS/kg /day, M = 50mg BPS/kg /day, H = 250mg BPS/kg /day, Total fat  
*p<0.05 significant difference compared to control (Vehicle). 









Fig S3. Steroidogenesis and steroid metabolism pathways.  
(A) Steroidogenesis pathway (B) Corticoids group metabolism pathway 
The red line indicates that the pathway involved in the steroid hormones and metabolites detected in this study 
(Adapted from Kegg pathways; Jeanneret et al., 2016) 
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Table S1. List of identified metabolites by UPLC-QTOF-MS 
 










5a-androstenedione 287.201 0.5 11.38 +H 
2 ESI+ 19-Oxotestosterone 303.195 -0.5 6.75 +H 
3 ESI- 16a-Hydroxyandrostenedione 301.1807 -0.2 11.02 -H 
4 ESI- 17a,21-Dihydroxypregnenolone 347.223 0.2 11.49 -H 
5 ESI- Androstanediol 291.234 1 11.26 -H 
6 ESI- Etiocholanolone 289.2178 0.5 10.87 -H 
7 ESI- Testolactone 299.1626 -2.6 11.4 -H 
8 ESI- Etiocholanolone 349.238 -0.5 6.52 +CH3COO 
9 ESI- 7a-Hydroxytestosterone 363.2184 0.7 5.51 +CH3COO 
10 ESI- Androsterone-3a-sulfate 429.1944 -0.9 7.56 +CH3COO 
11 ESI- 5a-androstenedione 285.1865 0.5 9.62 -H 
12 ESI- 5-Androstenediol 289.2174 0.1 9.89 -H 
13 ESI- DHEA 347.2221 -0.7 9.57 +CH3COO 
14 ESI+ 
Estrogens 
Estradiol 273.186 1.1 16.95 +H 
15 ESI+ Estrone-3-glucuronide 447.2005 -0.9 6.43 +H 
16 ESI+ 4-hydroxy-estradiol 289.1794 -0.5 16.21 +H 
17 ESI+ Estriol 289.1811 1.3 16.64 +H 
18 ESI+ Estrone 271.1676 -1.6 9.66 +H 
19 ESI+ 16a-Hydroxyestrone 287.1635 -0.7 10.98 +H 
20 ESI- Estriol 287.163 -2.3 11.02 -H 
21 ESI- Estrone-3-glucuronide 445.186 -0.8 7.29 -H 
22 ESI- Estradiol 331.1932 1.7 5.67 +CH3COO 
23 ESI- 2-methoxy-estradiol-3-glucuronide 477.2138 0.8 7.7 -H 
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Pregenolone 317.2492 1.7 11.3 +H 
26 ESI+ 17-Hydroxyprogesterone 331.2237 -3 6.44 +H 
27 ESI+ Pregnenolone-3b-sulfate 397.2024 -1.9 13.12 +H 
28 ESI+ Pregnanediol 321.2756 -3.2 11.18 +H 
29 ESI+ Progesterone 315.234 2.1 7.63 +H 
30 ESI+ 11b-Hydroxyprogesterone 333.2039 -2.1 6.31 +H 
31 ESI- Pregenolone 315.2335 0.5 11.02 -H 
32 ESI- Progesterone 313.2163 -1 11.02 -H 
33 ESI- 11b-Hydroxyprogesterone 391.214 1.3 11.04 +CH3COO 
34 ESI- 5a-Pregnane-20a-ol-3-one 377.2705 0.7 7.3 +CH3COO 
35 ESI- Pregnenolone-3b-sulfate 455.211 0.1 8.52 +CH3COO 
36 ESI- 11b,17a,21-Trihydroxypregnenolone 363.2185 0.8 9.17 -H 
37 ESI- 17,20a-Dihydroxy-4-pregnen-3-one 391.2515 2.5 10 +CH3COO 
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Table S1. Continued 










21-deoxycortisol 347.2211 -0.6 5.19 +H 
39 ESI+ 3,21-Dihydroxy-5b-pregnane-11,20-dione 349.235 0.7 4.66 +H 
40 ESI+ Deoxycortisol 347.2205 -1.2 5.36 +H 
41 ESI+ 11β,17α,21-Trihydroxy-5β-pregnane-3,20-dione 365.2303 -2 3.55 +H 
42 ESI+ Corticosterone 347.2201 -1.6 4.89 +H 
43 ESI+ 21-Hydroxy-5b-pregnane-3,11,20-trione 347.2184 -3.3 4.31 +H 
44 ESI+ Allotetrahydrodeoxycorticosterone 335.2573 -0.8 10.87 +H 
45 ESI+ 17a,21-Dihydroxy-5b-pregnan-3,11,20-trione 363.2178 1.2 8.08 +H 
46 ESI+ 18-hydroxycorticosterone 363.2161 -0.5 17.48 +H 
47 ESI+ Cortisol 363.2149 -1.7 4.75 +H 
48 ESI- 11-dehydroxycorticosterone 389.2299 -3.4 11.02 +CH3COO 
49 ESI- Tetrahydrocorticosterone 349.2373 -1.1 12.7 -H 
50 ESI- 11β,21-Dihydroxy-3,20-dioxo-5β-pregnan-18-al 421.2262 3 11.68 +CH3COO 
51 ESI- Urocortisol 365.2346 1.2 11.71 -H 
52 ESI- 11β,17α,21-Trihydroxy-5β-pregnane-3,20-dione 363.2171 -0.6 5.32 -H 
53 ESI- 11-Deoxycortisol 345.2096 2.4 9.33 -H 








비스페놀 S의 태중 노출로 인한 C57BL/6 
마우스 내의 스테로이드 합성 및 대사 경







비스페놀 S (BPS)는 비스페놀 A (BPA)의 대체제로 폴리카보네
이트 플라스틱, 에폭시 수지 등 다양한 생활용품에 사용되는 물질이
다. 국내에서는 BPA의 대체재로 BPS를 주로 사용하고 있으며, 그 
사용량이 점차 증가하고 있음에도 불구하고 BPS의 내분비계 교란 
작용에 대한 연구는 부족한 실정이다. 따라서 본 연구에서는 BPS의 
태중 노출로 인한 F1세 대의 스테로이드 호르몬 합성 및 대사 변화
를 관찰하고자 한다. 이를 위해 C57BL/6 임신마우스에게 약 10일 
(재태기간 9일 – 출산일) 동안 식수를 통해 BPS를 5mg/kg/day, 
50mg/kg/day, 250mg/kg/day로 노출시켰다. 노출된 임신마우스에
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게서 태어난 F1세대를 각 8주령, 23주령에 희생하여 신체계측치, 
혈청, 지방, 생식기를 포함한 장기를 수집하였다. 수집된 혈청 중 일
부는 시상하부-뇌하수체-생식샘 축(HPG axis)에 관여하는 호르몬 
6종(생식선자극호르몬방출호르몬(GnRH), 여포자극호르몬(FSH), 
황체형성호르몬(LH), 프로게스테론(P4), 테스토스테론(T), 에스트
라디올(E2))을 ELISA kit로 측정하였다. 또한, UPLC-qTOF를 이
용하여 혈청내의 스테로이드 호르몬의 합성 및 대사과정에 존재하
는 모든 스테로이드 호르몬 및 그 대사체들을 측정하였다. 신체계측
치의 경우 일반 선형 모델분석 (general linear model analysis) 결
과 각 항목은 성별, 주령, 노출 농도에 따라 현저하게 다른 경향성
을 나타내었다. 특히, 암, 수 모두 성인기 (23주령) 보다는 사춘기 
(8주령)에 유의한 차이를 나타내었다. 시상하부-뇌하수체-생식샘 
축에 관여하는 호르몬들의 측정 결과, 8주령 암, 수 마우스 그룹에
서 대조군 대비 250mg/kg bw/day 그룹은 GnRH가 높아짐에 따라 
LH가 높아지고 T의 수치가 높아지는 경향을 보였다. 스테로이드 
호르몬의 합성 및 대사에 관여하는 대사체들은 23주령 암, 수 마우
스 그룹과 8주령 수컷마우스의 모든 농도에서 pregenolone으로부
터 tetrahydrocorticosterone 방향으로의 대사과정에 두드러진 경
향을 보였다. 본 연구는 BPS in vitro 실험 결과와 비교해볼 때, 에
스트로겐 활성에 미미한 변화를 일으키는 역할을 한다는 것과 달리 
안드로겐 활성을 일으키는 역할을 한다는 결과를 얻었다. 그러나 부
신에서의 스테로이드 호르몬 합성과정의 관찰이 부족하여 UPLC-
qTOF 측정결과를 설명하기엔 어려움이 있다. 연구 결과, BPS의 태
중 노출로 인한 신체계측치 및 호르몬들의 영향은 노출된 BPS의 
농도에 따라, 성별에 따라, 관측시기에 따라 확연히 다른 경향성을 
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나타낸다는 것을 확인하였다. 또한 본 연구는 설치류에서 BPS의 태
중 노출로 인한 스테로이드 호르몬 합성 및 대사과정의 순환체계의 
변화에 관한 정보를 일부 제공하며 BPS의 독성 기전 연구에 활용
될 수 있을 것이다. 
 
주요어 : 비스페놀 S, 태중 노출, HPG axis, 스테로이드 합성 및 대
사, 안드로겐 활성 
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